Bioactive Compounds
-
N2891 Trimethylamine oxide dihydrateSummary: ROS/NLRP3 activator; TGF-β/Smad2 signaling pathway activator -
C8734 Doxycycline hydrochlorideSummary: A broad-spectrum tetracycline antibiotic that primarily inhibits the bacterial ribosomal 30S subunit, thereby blocking protein synthesis -
N2889 HexadecanamideSummary: A fatty acid amide derived from palmitic acid, commonly used to study its anti-inflammatory and neuroprotective effects -
C8749 NADHSummary: Reduced-form coenzymes, whose core biological function is to participate in energy metabolism processes such as glycolysis, the tricarboxylic acid (TCA) cycle, and the mitochondrial electron transport chain. -
C3816 PentoxifyllineSummary: A phosphodiesterase (PDE, especially PDE IV) inhibitor -
C8696 Amikacin SulfateSummary: An aminoglycoside antibiotic that exerts dose-dependent bactericidal activity mainly against Mycobacterium avium (Mycobacterium avium, MAC) and Staphylococcus aureus (Staphylococcus aureus). -
C8702 RomiplostimSummary: Recombinant “peptibody”-type thrombopoietin receptor (TPO-R, MPL) agonist -
C8705 SemaglutideSummary: GLP-1 receptor agonist -
N2892 PristaneSummary: A compound that can be used to induce animal models of rheumatoid arthritis and systemic lupus erythematosus-like syndrome. -
C8752 SEL120-34A hydrochlorideSummary: An ATP-competitive inhibitor of CDK8/CDK19

